93X Stock Overview A nutraceutical company, engages in the development of nutritional products in Canada and the United States. More details
Risk Analysis + 3 more risks
See All Risk Checks Capture your thoughts, links and company narrative
Promino Nutritional Sciences Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for Promino Nutritional Sciences Historical stock prices Current Share Price CA$0.026 52 Week High CA$0.21 52 Week Low CA$0.016 Beta 2.62 1 Month Change -35.00% 3 Month Change -32.47% 1 Year Change -75.24% 3 Year Change -97.15% 5 Year Change n/a Change since IPO -98.41%
Recent News & Updates
Promino Nutritional Sciences Inc. Begins Preclinical Trial to Demonstrate Effectiveness of Promino™ Patented IP for Retention of Muscle Mass in Cancer Patients Undergoing Aggressive Chemotherapy Treatment Sep 18
Promino Nutritional Sciences Inc. Announces the Release of Results of A New Human Clinical Trial Sep 09
Second quarter 2024 earnings released: CA$0.042 loss per share (vs CA$0.028 loss in 2Q 2023) Sep 05 Promino Nutritional Sciences Inc. announced that it has received CAD 1.749001 million in funding Jul 10
Promino Nutritional Sciences Inc., Annual General Meeting, Jul 09, 2024 May 15
Full year 2023 earnings released: CA$0.15 loss per share (vs CA$0.29 loss in FY 2022) May 09 See more updates
Promino Nutritional Sciences Inc. Begins Preclinical Trial to Demonstrate Effectiveness of Promino™ Patented IP for Retention of Muscle Mass in Cancer Patients Undergoing Aggressive Chemotherapy Treatment Sep 18
Promino Nutritional Sciences Inc. Announces the Release of Results of A New Human Clinical Trial Sep 09
Second quarter 2024 earnings released: CA$0.042 loss per share (vs CA$0.028 loss in 2Q 2023) Sep 05 Promino Nutritional Sciences Inc. announced that it has received CAD 1.749001 million in funding Jul 10
Promino Nutritional Sciences Inc., Annual General Meeting, Jul 09, 2024 May 15
Full year 2023 earnings released: CA$0.15 loss per share (vs CA$0.29 loss in FY 2022) May 09 Promino Nutritional Sciences Inc. (CNSX:MUSL) entered into a binding letter of intent to acquire Helios Helium Corp. for CAD 5.84 million. Apr 30
New major risk - Shareholder dilution Feb 13 Promino Nutritional Sciences Inc. announced that it has received CAD 2.208075 million in funding Feb 07
Promino Nutritional Sciences Inc. announced that it has received CAD 2.208075 million in funding Feb 06
New major risk - Financial position Nov 30
Element Nutritional Sciences Inc. Appoints Adam Berk as Advisor Oct 12 Element Nutritional Sciences Inc. Announces Executive Changes
New minor risk - Shareholder dilution Aug 27
Element Nutritional Sciences Inc. Rethinks Protein with Launch of Exclusive Patented PROMINO™ Brand Drink Mix and Ready-to-Drink Beverages Aug 04 Element Nutritional Sciences Inc. announced that it has received CAD 1.9065 million in funding Jul 15
New major risk - Financial position Jun 18
Full year 2022 earnings released: CA$0.097 loss per share (vs CA$0.10 loss in FY 2021) Jun 17 Element Nutritional Sciences' Announces Loblaws to Launch RejuvenateTM Muscle Activator
Element Nutritional Sciences' Rejuvenate™ Muscle Activator Scores Ahead of Popular Protein Sources in Protein Quality Measurement Jun 08
Element Nutritional Sciences' RejuvenateTM Muscle Activator Now on Shelves at Shoppers Drug Mart and Loblaws Jan 17
Element Nutritional Sciences Inc., Annual General Meeting, Feb 21, 2023 Dec 26
Third quarter 2022 earnings released: CA$0.023 loss per share (vs CA$0.031 loss in 3Q 2021) Dec 01
Element Nutritional Sciences Inc., Annual General Meeting, Dec 23, 2022 Nov 22
High number of new and inexperienced directors Nov 16 Element Nutritional Sciences Inc. announced that it expects to receive CAD 1 million in funding Nov 08
Second quarter 2022 earnings released: CA$0.016 loss per share (vs CA$0.038 loss in 2Q 2021) Sep 01
First quarter 2022 earnings released: CA$0.011 loss per share (vs CA$0.023 loss in 1Q 2021) Aug 01
Element Nutritional Sciences Inc. Launches Clinical Strength Rejuvenate for Institutional Market Jul 27
Element Nutritional Sciences Inc. Enter Commercial Production for Rejuvenate Muscle Activator Jul 21
Element Nutritional Sciences Inc. Announces RejuvenateTM Immune Health Now Available Through Amazon.com Jul 14
Element Nutritional Sciences Completes Production Trials for Rejuvenate™ Muscle Activator May 31
Element Nutritional Sciences Inc. Provides Earnings Guidance for the First Quarter Ended March 31, 2022 May 16 Element Nutritional Sciences Inc. has completed a Follow-on Equity Offering in the amount of CAD 3.5 million. May 08
High number of new and inexperienced directors Apr 27
Element Nutritional Sciences Inc. Announces the Resignation of Tracie Crook from the Board of Directors Feb 24
Element Nutritional Sciences Announces Rejuvenate Available At All Sam's Club Across the United States Jan 25
Third quarter 2020 earnings: Revenues and EPS in line with analyst expectations Dec 02
Element Nutritional Sciences to Launch Innovative Sports Nutrition Product Under JAKTRXTM Brand Sep 24
Less than half of directors are independent Sep 15
Less than half of directors are independent Sep 10
Less than half of directors are independent Sep 07
Less than half of directors are independent Sep 01
Element Nutritional Sciences Announces Rejuvenate™ Now Available at Sam’s Club Jul 15
Element Nutritional Sciences Inc. announced that it has received CAD 5.0004 million in funding Jun 20 Shareholder Returns 93X DE Personal Products DE Market 7D -10.3% 1.0% 0.6% 1Y -75.2% -7.1% 7.2%
See full shareholder returns
Return vs Market: 93X underperformed the German Market which returned 7.2% over the past year.
Price Volatility Is 93X's price volatile compared to industry and market? 93X volatility 93X Average Weekly Movement 51.5% Personal Products Industry Average Movement 3.6% Market Average Movement 4.9% 10% most volatile stocks in DE Market 11.7% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: 93X's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 93X's weekly volatility has increased from 33% to 51% over the past year.
About the Company Promino Nutritional Sciences Inc., a nutraceutical company, engages in the development of nutritional products in Canada and the United States. The company offers Rejuvenate, a proprietary formulation to assist in the rebuilding, restoration, and rejuvenation of natural loss of muscle mass due to aging or other medical conditions; and protein powders and other nutritional supplements under Promino and JAKTRX brands for both professional and amateur athletes to accelerate muscle recovery, build strength, and accelerate recovery from injury. It also engages in retailing of its products through stores and online.
Show more Promino Nutritional Sciences Inc. Fundamentals Summary How do Promino Nutritional Sciences's earnings and revenue compare to its market cap? 93X fundamental statistics Market cap €3.05m Earnings (TTM ) -€7.72m Revenue (TTM ) €163.99k
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 93X income statement (TTM ) Revenue CA$246.08k Cost of Revenue CA$988.30k Gross Profit -CA$742.22k Other Expenses CA$10.84m Earnings -CA$11.58m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) -0.10 Gross Margin -301.62% Net Profit Margin -4,707.82% Debt/Equity Ratio -45.2%
How did 93X perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/30 08:52 End of Day Share Price 2024/12/27 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Promino Nutritional Sciences Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
